Sulpiride in the Treatment of Somatoform Disorders: Results of a European Observational Study to Characterize the Responder Profile

Author： Rouillon F Rahola G Van Moffaert M Lopes R Guimaraes Dunia J

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.29, Iss.4, 2001-07, pp. : 304-313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The present nosography of somatoform disorders: results of the Italian epidemiological study of somatoform disorders

By Tacchini G. Musazzi A. Recchia M. Altamura A.C. Carta M.G.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial

By Volz H.-P. Moller H.-J. Reimann I. Stoll K.-D.

European Neuropsychopharmacology, Vol. 10, Iss. 3, 2000-05 ,pp. : 211-217

Elsevier

Access to resources Recommend Favorite

WHO international study of somatoform disorders -- a review of methods and results

By Janca A.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 175-175

Elsevier

Access to resources Recommend Favorite

Nefazodone in the Treatment of Elderly Patients with Depressive Disorders: A Prospective, Observational Study

By Saiz-Ruiz J.

CNS Drugs, Vol. 16, Iss. 9, 2002-01 ,pp. : 635-643

Adis International

Access to resources Recommend Favorite

Psychopharmacological treatments of somatoform disorders

By Altamura A.C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 176-177

Elsevier

Access to resources Recommend Favorite